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Sllnlmary 
Retinoic acid (RA) stimulates the clonal proliferation of mature bone marrow progenitor cells 
and  inhibits  the  growth  of leukemic progenitors,  whereas its  effects on  normal primitive 
hematopoietic progenitors have not yet been investigated. This study investigated the ability 
of all-trans- and 9-c/s-RA to modulate the proliferation and differentiation of murine Lin-Sca-1 § 
bone marrow progenitor cells. Both RA isoforms inhibited in a reversible  and dose-dependent 
fashion, the proliferation of multi- but not single-factor responsive Lin-Sca-1 + progenitor cells. 
The 50% effective dose was 10 nM for both all-trans- and 9-c/s-RA. Maximum inhibition was 
observed at 100-1,000 nM RA, resulting in a 50-75% reduction in the number of proliferative 
clones. Lin-Sca-1 + cells with high proliferative potential were preferentially inhibited by RA, 
resulting in a 80-100%  inhibition depending on the hematopoietic growth factors stimulating 
their growth. The inhibitory effects of ILA were directly mediated on the target cell, since the 
effects were observed at the single cell level. Furthermore, autocrine transforming growth factor 
(TGF-3) production can probably not account for the observed inhibitory effects of RA, since 
a TGF-3 neutralizing antibody did not block RA-induced inhibition. Whereas RA, in general, 
is a differentiation-inducing agent, treatment of Lin-Sca-1 + progenitors resulted in the accu- 
mulation of an increased fraction of blasts  and immature myeloid cells. Thus, RA inhibits the 
proliferation as well as differentiation of normal primitive hematopoietic progenitor cells. 
T 
he proliferation and differentiation of pluripotent and 
committed hematopoietic progenitor cells is controlled 
by a complex network of cytokines and cell to cell interac- 
tions (1-5). ILetinoic acid (P.A) is an oxidized derivate of retinol 
demonstrated to play an important role in the growth and 
differentiation of a number of cell types, including epithelial 
and hematopoietic cells (6-8). In contrast to cytokines, vitamin 
A cannot be synthesized endogenously, and is therefore con- 
sidered an essential nutrient (9). RA has been demonstrated 
to induce granulocytic differentiation of HL-60,  a human 
promyelocytic  leukemia cell line, as well as fresh acute promye- 
locytic leukemia cells (APL) (10,  11), resulting in complete 
remissions in APL patients (12,  13). Whereas all-trans-RA 
mediates its effects through the RA receptors (RARs) (14, 
15),  another RA isoform, 9-cis-RA,  signals  through both 
the RAILs as well as another group of transcription factors, 
the retinoid X  receptors (RXILs)  (16). 
A striking feature of RA is its apparent opposing actions 
on the growth of normal and malignant myeloid progenitor 
cells, in that it stimulates the myeloid growth of normal bone 
marrow progenitor cells (7,  8,  17-21),  whereas it inhibits 
the  proliferation  of acute  myelogenous leukemia cells  in 
vitro (22). 
Previous studies have only examined the effects of RA on 
unfractionated bone marrow cells, where committed progen- 
itor cells dominate. Thus, potential effects of RA on primi- 
tive progenitor cells remain undetermined. In this study we 
therefore examined the direct effects of escalating concentra- 
tions of all-trans and 9-c/s ILA on murine Lin-Sca-1 + bone 
marrow cells, previously shown to be highly enriched in primi- 
tive hematopoietic progenitor cells (23, 24), to possess high 
radioprotective efficiency, and capability of long-term recon- 
stitution of all cell lineages in the blood (23,  24). 
Materials and Methods 
RA, Hematopoietic Growth Factors, and Antibodies.  All-trans-RA 
was purchased from Sigma Chemical Co. (St. Louis, MO), whereas 
9-c/s-RA was a gift from Hoffmann-La Roche (Basel, Switzerland). 
Purified recombinant human (rHu) G-CSF, recombinant murine 
(rMu)GM-CSF, and recombinant rat (rr) stem cell factor (SCF) 
were generously supplied by Drs. Ian K. McNiece, Thomas C. 
Boone, and Keith E. Langley  (Amgen Corp., Thousand Oaks, CA). 
1665  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/94/05/1665/06  $2.00 
Volume 179  May 1994  1665-1670 rMulL-3 was purchased from Peprotech Inc. (Rocky Hill, NJ). 
rHuCSF-1 was kindly provided  by Dr. Michael Geier (Cetus Corp., 
Emeryville, CA). rHull.,6 was a generous gift from Genetics Insti- 
tute (Cambridge, MA), purified rHulL-lot was kindly supplied by 
Hoffmann-La Roche, and rHuTGF-/31 was provided by Tony Pur- 
chio (Oncogene Corp., Seattle, WA). Unless otherwise indicated, 
all growth factors were used at predetermined optimal concentra- 
tions: rMuGM-CSF, 20 ng/ml; rHuG-CSF, 20 ng/ml; rMu IL-3, 
20 ng/ml; rHuCSF-1, 50 ng/ml; rrSCF, 100 ng/ml; rHulIAot, 20 
ng/ml; rHulL-6, 50 ng/ml; and rHuTGF-B1, 2 ng/ml. 
A  neutralizing  mouse  IgG1 antibody  against TGF-/31 and 
TGF-/32 was a gift from Dr. James R. Dash (Celtrix Laboratories, 
Palo Alto, CA). This antibody neutralizes the effects of mouse as 
well as human TGF-/31 and TGF-/32 (25, 26). An isotype-matched 
irrelevant antibody was used as a control. 
Isolation of Lin-Sca-1 + Bone Marrow  Cells.  Lin-Sca-1  + cells 
were isolated from C57BL6 mice as previously described (24, 27). 
Briefly, 4-6  x  107 Lin- cells (27) were resuspended per milliliter 
of complete IMDM and incubated for 30 min on ice with either 
PlTC-conjugated rat anti-mouse Ly-6A/E antibody (Pharmingen, 
San Diego, CA) or an isotype-matched control antibody. The cells 
were washed twice, and Lin-Sca-1 + cells sorted on a cell sorter 
(Epics Elite; Coulter Electronics, Hialeah, FL). The final recovery 
of Lin-Sca-1 + cells was 0.05-0.1%  of the unfractionated bone 
marrow. In agreement with others (24), as few as 100 of these cells 
could protect 50% of lethally irradiated mice (data not shown). 
Colony Formation in Semisolid Medium.  A modification of the 
method described  by Stanley  et al. (28) was used to measure colony 
formation  of murine bone  marrow  progenitors in vitro.  Lin- 
Sca-1 + bone marrow cells were plated in complete IMDM and 
0.3% Seaplaque agarose (FMC Bioproducts, Rockland, ME) and 
incubated at 37~  in 5%  CO2 for 7 d and scored for colony 
growth (>50 cells). 
High Proliferative Potential Colony-forming Cell (HPP-CFC) Assay. 
The HPP-CFC assay  was performed  as previously  described  by others 
(29). Alpha modification of Eagle's MEM (MEM-AIpha, GIBCO 
BRL, Gaithersburg, MD) supplemented with 20% FCS (Sera Lab, 
Sussex, UK) and t-glutamine was used in all HPP-CFC assays. 
Cytokines were incorporated into a 1-ml underlayer at a maximum 
of 3% of the culture volume, and 600 Lin-Sca-1 + ceils were in- 
corporated into a 0.5-ml ovedayer. The final concentration of Sea- 
plaque agarose was 0.5% in the underlayer and 0.3% in the over- 
layer. HPP-CFC colonies were scored as dense colonies with a 
diameter of 2>0.5 mm after 12-14 d of incubation at 37~  5% 
02, 10% CO2, and 85% N2. 
Single CellProliferation Assay.  Lin-Sca-1 + were seeded in Ter- 
asaki plates (Nunc, Kamstrup, Denmark) at a concentration of  one 
cell per well in a volume of 20 #1 complete IMDM. Wells were 
scored for colony growth (>50 cells) and clusters (10-50 ceils) after 
12 d of incubation at 37~  and 5% CO2 in air. 
Cell Phenotyping.  Lin-Sca-1 + cells were plated in complete 
IMDM and incubated for 12-14 d with predetermined  optimal con- 
centrations of cytokines and RA at 37~  and 5% CO2 in air. Cell 
morphology was determined following Giemsa  staining ofcytospin 
preparations. 
Results and Discussion 
To investigate the ability of RA to affect the proliferation 
of primitive progenitor cells, single Lin-Sca-1 + cells were 
stimulated by rrSCF and rHuIL-6 in the absence or presence 
of increasing concentrations ofall-trans- or 9-c/s-RA (Fig. 1). 
In light of most previous studies suggesting that RA stimu- 
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Dos~on~  of ~-trans- ~d 9-c~-~ on proliferation  of 
single Lin- Sca-1 + progenitor  cells. Lin- Sca-1  + cells  were plated at a den- 
sity  of  one cell  per well  in microtiter  wells  in complete  IMDM supplemented 
with SCF (100 ng/ml) and Ib6 (50 ng/ml), and exposed to increasing 
concentrations  of all-trans-  or 9-c/s-RA as indicated.  Wells  were scored  for 
growth (>10 cells) after a 12-14-d incubation  at 37~  and 5% CO2 in 
air. Results are the mean (+  SEM) of four separate experiments. 
lates the proliferation of normal myeloid bone marrow pro- 
genitor cells (7,  8,  17-21),  it was surprising that both all- 
trans-  and 9-c/s-RA inhibited Lin-Sca-1 + colony formation 
in a concentration-dependent manner. The 50% effective dose 
(EDs0) was "~10 nM for both all-trans-  and 9-c/s-RA  (Fig. 
1). Furthermore, all-trans-  and 9-c/s-RA showed comparable 
concentration-response curves, resulting in a >80% inhibition 
of colony  formation at 100-1,000  nM aU-trans- or 9- c/s-RA 
(Fig.  1).  These inhibitory concentrations of all-trans-  and 
9-c/s-RA are comparable with concentrations of  retinoids pre- 
viously shown to be inhibitory on leukemic hematopoiesis 
in vitro (17, 19, 22).  Furthermore, the inhibitory effects of 
9-c/s-RA  and aU-trans-RA  were completely reversible after 
exposure of Lin- Sca-1 + cells to 1,000 nM of either isoform 
for 12-24 h  (data not shown). 
Next, the effects of 100 nM 9-c/s-RA or aU-trans-RA were 
investigated on proliferation of single Lin-Sca-1 + cells stim- 
ulated by other growth factor combinations (Table 1).  As 
previously reported, the Lin-Sca-1 + progenitors responded 
poorly to single hematopoietic growth factors  (HGFs) ex- 
cept IL-3 (29),  and single-factor-induced colony formation 
was not or only marginally inhibited by both RA isoforms 
(data not shown). In contrast, a number of two-factor com- 
binations potently stimulating colony formation of Lin-Sca- 
1 + progenitors were inhibited by both 9-c/s-RA  (Table 1) 
and all-trans-RA  (data not shown). Since most primitive he- 
matopoietic progenitor cells in contrast to committed pro- 
genitors require more than one HGF to proliferate (28-30), 
this suggested that RA might preferentially inhibit early he- 
matopoiesis. This was further supported by the observation 
that whereas the formation of clusters and small colonies was 
only marginally affected by RA treatment, larger colonies, 
and in particular those covering >50% of the culture well, 
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nM  9-c/s-RA (Table  1)  or all-trans-RA  (data not  shown). 
Since some heterogeneity has been demonstrated within 
the Lin-Sca-1 + population of bone marrow cells  (30),  we 
next examined the ability of 9-c/s-RA to inhibit Lin-Sca-1 + 
HPP-CFCs. The HPP-CFC assay has been shown to detect 
some of the most immature hematopoietic progenitor cells 
measurable in vitro, and HPP-CFCs are characterized by the 
requirement of multiple HGFs for proliferation (29, 31). The 
formation of HPP-CFC colonies by Lin-Sca-1 + celli stimu- 
lated by IL-3 +  SCF as well as several three-factor combina- 
tions were inhibited  80%  or more by 9-cis-RA  (Fig.  2). 
Next,  we examined whether  the antiproliferative  effects 
of RA were accompanied by effects on differentiation as well. 
It is interesting to note that when Lin-Sca-1 + were stimu- 
lated by SCF  +  IL-3, preferentially stimulating the produc- 
tion of macrophages, addition of RA resulted in a twofold 
increase in the relative number of granulocytes and a con- 
comitant 72%  reduction in the relative number of macro- 
phages (Table  2). In contrast, when Lin-Sca-1 + were stimu- 
lated  by  SCF  +  G-CSF,  resulting  in  the  formation  of 
predominantly granulocytes, RA did not significantly affect 
the  relative  production  of granulocytes  and  macrophages. 
However, for both combinations, a three- to fourfold increase 
in the relative number of immature blasts was observed (Table 
2, Fig. 3). This suggested that RA might exert its antiprolifer- 
ative effects,  partially by inhibiting  myeloid differentiation 
of Lin-Sca-1 + progenitor cells.  This is of particular interest 
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Figure 2.  The effect of 9-c/s-RA  on HPP-CFCs. Lin-Sca-1  + cells were 
isolated and plated (600/plate) into a double-layer agarose culture in the 
presence of  predetermined optimal concentrations  of  cytokines  as described 
in Materials and Methods. Cultures were scored for HPP-CFC growth 
after 14 d of incubation in 5% 02, 10% CO2, and 85% N2, at 37~ 
in the presence or absence of 1,000 nM 9-c/s-RA. The results represent 
the mean (+  SEM) of duplicate determinations in at least four separate 
experiments. (*) No HPP-CFC colonies observed. 
since RA is considered a differentiation inducing agent (9, 
10).  Thus,  tLA might  inhibit  the  proliferation  as  well  as 
differentiation  of primitive  hematopoietic progenitor cells. 
RA  has  been  demonstrated  to  induce  TGF-fl  protein 
Table  1.  Effects of 9-cis-RA  on Proliferation of Single Lin-Sca-1 § Bone Marrow Progenitor Cells 
Degree of cell 
proliferation* 
Total clones/ 
Cytokines  9-cis-RA  1  2  3  4  300 cells 
IL-3 + SCF  -  4  6  10  29  49 (7) 
IL-3 + SCF  +  4  4  6  5  19 (3) 
IL-3 + IL-6  -  5  10  8  9  32 (5) 
IL-3 + IL-6  +  3  6  3  1  13  (2) 
IL-3 + GM-CSF  -  4  4  4  7  19 (3) 
IL-3 + GM-CSF  +  2  4  2  2  10 (1) 
IL-6 + SCF  -  5  11  13  30  59 (7) 
IL-6 + SCF  +  4  3  4  1  12 (2) 
G-CSF + SCF  -  5  11  9  26  51  (8) 
G-CSF + SCF  +  5  8  4  1  18 (3) 
CSF-1 + SCF  -  3  3  5  6  17 (3) 
CSF-1 + SCF  +  3  2  1  0  6 (1) 
Lin-Sca-1 + cells were separated as described in Materials and Methods and plated at one cell per well in 20 #1 complete IMDM and predetermined 
optimal concentrations of cytokines. Cultures were incubated in the presence or absence of 9-c/s-RA (10 -7 M) for 12-14 d at 37~  5% CO2 in 
air, and scored for different degrees of cell growth. 
* Scoring criteria 1, 10-50 cells; 2, 50 cells-lO% of well covered by cells; 3, 10-50% of well covered; 4, >50% of well covered. Results represent 
the mean (SEM) of three separate experiments. No proliferation was observed in the presence of medium or 9-c/s-RA alone. 
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marrow cells. 500-2,000  Lin-Sca-1 + bone marrow cells were plated in 
complete IMDM supplemented  with predetermined  optimal concentra- 
tions of G-CSF and SCF in the absence (A) or presence (B) of 100 nM 
9-c/s-RA.  After  12-14  d  of incubation  at  37~  and  5%  CO2  in  air, 
cytospins  were stained  with Giemsa.  Original magnification  at  1,000. 
production in a human promyelocytic  leukemia cell line (HL- 
60) (32),  and it has also been suggested that normal hemato- 
poietic progenitor cells can produce TGF-3 (33).  However, 
in this study the inhibition by 9-c/s-tLA was not significantly 
affected by a neutralizing TGF-3  antibody (Table  3),  sug- 
gesting that the inhibitory effects of 9-cis-RA are not medi- 
ated through autocrine TGF-3 production. Since this anti- 
body has only been demonstrated to  neutralize the effects 
of TGF-31  and TGF-32,  it cannot be excluded that TGF- 
fl3, the third TGF-3 isoform expressed in mammals, might 
be involved in the observed RA-induced growth inhibition 
of Lin-Sca-1 + progenitor  cells.  However,  this  seems  un- 
likely for several reasons.  First, in the previous study demon- 
strating autocrine production of TGF-B by hematopoietic pro- 
genitor cells, a neutralizing antibody to TGF-31 could block 
all the inhibitory response (33).  Second, the ability of RA 
to induce TGF-3 production in the HL-60 cell line was ex- 
clusively due to enhanced TGF-31 expression, whereas TGF-32 
and TGF-fl3 expression was not affected (32). Thus, although 
RA might induce TGF-3 secretion, these findings suggest 
that the inhibitory effects of RA on primitive hematopoietic 
progenitor cells can be mediated through alternative mech- 
anisms. 
The present data suggests that all-trans- and 9-c/s-RA are 
potent inhibitors of proliferation of primitive hematopoietic 
progenitor cells. Whereas this is in line with what has been 
previously demonstrated on myeloid leukemic cells (17,  19, 
22), it is in contrast to the stimulatory effects shown on normal 
human bone marrow progenitors (7, 8, 17-21). This apparent 
discrepancy could be due to the fact that these previous studies 
have only studied RA effects on unfractionated bone marrow 
cells. Thus,  the observed effects in those studies would be 
more representative of  committed progenitors than the primi- 
tive ones investigated here. Proliferative effects on unfractio- 
hated bone marrow can also be a consequence of indirect effects 
through induction of accessory cells to cytokine production. 
In contrast, RA effects in this study were observed on highly 
enriched progenitors in single cell experiments, suggesting 
that the observed inhibitory effects were directly mediated 
on the progenitors, although autocrine mechanisms cannot 
be excluded. 
Other studies from our laboratory suggest that the effects 
of RA on CSF-induced proliferation of committed CD34 § 
human progenitors are strictly dependent on the specific CSF 
with which it interacts, in that it potently inhibits G-CSF-in- 
duced colony formation while it synergizes with GM-CSF 
(Smeland,  E.  B.,  L.  S.  Kusten,  S.  E.  W.  Jacobsen,  and 
Table  2.  Effects  of 9-cis-RA  on  Differentiation  of Lin-Sca-1 + Bone Marrow  Cells 
Growth  factors  9-c/s-RA  Percent  granulocytes  Percent  macrophages  Percent blasts 
IL-3  +  SCF  -  27 (8)  67 (7)  7 (3)) 
IL-3  +  SCF  +  59 (10)  19 (10)  23 (6) 
G-CSF  +  SCF  -  89 (5)  6 (3)  5 (2) 
G-CSF  +  SCF  +  77 (5)  3 (2)  20 (5) 
500-2,000 Lin-Sca-1 § cells were seeded in 0.5-1  ml complete IMDM supplemented  with optimal concentrations  of cytokines  (see Materials  and 
Methods)  as indicated,  and in the absence or presence of 9-cis-RA 100 nM. Cytospin preparations  of individual  cultures  were stained with Giemsa 
for morphological characterization  after  12-14 d of incubation at 37~  and 5% CO2 in air.  Results represent  the mean (SEM) of four separate ex- 
periments. 
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Stimulation  Anti-TGF-/3  Colonies/300  cells 
IL-6 + SCF  -  53  (3) 
IL-6 + SCF  +  61  (5) 
IL-6 + SCF + TGF-31  -  3  (2) 
IL-6 + SCF + TGF-31  +  48  (7) 
IL-6 + SCF + 9-cis-RA  -  8  (3) 
IL-6 + SCF + 9-cis-RA  +  14  (3) 
Lin-Sca-l+ cells were separated as described in the Materials and Methods and plated at a density of one cell per well in 20 #1 complete IMDM 
supplemented with IL-6 (50 ng/ml), SCF (100 ng/ml), TGF-/~I (20 ng/ml), and 9-c/s-RA (100 riM) as indicated. Cultures were incubated in the 
absence ( - ) or presence ( + ) of 25 #g/ml of a neutralizing anti-TGF-B antibody. An irrelevant control antibody had no effect on colony formation. 
Colony formation (>10 cells) was scored after 12-14 d of incubation at 37~  and 5% CO2 in air. The results represent the mean number of colo- 
nies (SEM) from four separate experiments, with 300 wells scored per group in each experiment. 
H. K. Blomhoff, manuscript in preparation).  KA therefore 
emerges as a pleiotropic regulator of normal hematopoiesis, 
with potent direct inhibitory effects on primitive progenitors, 
and bidirectional  effects on committed  progenitors. 
We found all-trans- and 9-cis-PA to be equipotent inhibi- 
tors  of  Lin-Sca-1 +  progenitor  cells.  A  recent  study  on 
human bone marrow cells found  the range of activities  of 
the two isoforms to be similar, but 9-cis-gA slightly more 
potent than all-trans-RA (19). Whether all-trans- and 9-c/s-RA 
in fact have differential effects on hematopoiesis will require 
further studies, including assessments of the relative expres- 
sion of PARs  and  KXKs  on  hematopoietic progenitors. 
In conclusion, all-trans- and 9-c/s-KA are potent inhibitors 
of primitive bone marrow progenitor cells in vitro, and might 
therefore not have opposing actions on normal and leukemic 
myeloid progenitor  cells  as previously suggested. 
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